Tag Archives: ip

Mayo v. Prometheus – A European View

A Guest Post from Paul Cole, European Patent Attorney, Lucas & Co; Professor of IP law, Bournemouth University. Is a claim to an assay patent-eligible when all its features are known save for how it should be interpreted? The interpretation … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | 3 Comments

Supreme Court Remands In Myriad Appeal

Today, as predicted by many commentators, the Supreme Court set aside the ruling by the Fed. Cir. that claims to isolated DNA sequences that are the BRCA 1 or 2 gene, or fragments thereof, are patentable subject matter. The Supreme … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , | 1 Comment

“Handbook of Quality Procedures Before the EPO”

The ECP, epi and Business Europe have collaborated to produce a downloadable, fifty page guide to practice before the EPO. While not binding on Examiners, it was issued under the authority of the EPO and is a sort of mini-MPEP, … Continue reading

Posted in EP and UK Practice | Tagged , , , , , , , , | Leave a comment

Indian Patent Office Grants Compulsory License To Bayer Drug

Finding that Bayer had failed the requirement to “work” the invention in India, e.g., manufacture and sell at a reasonable price, the Indian Patent Office granted Natco Pharma, an Indian company, a “compulsory license” to make, use and sell  a … Continue reading

Posted in Working Requirements | Tagged , , , , , , , , , , , , | 1 Comment